
Alloxazine
CAS No. 490-59-5
Alloxazine( —— )
Catalog No. M27527 CAS No. 490-59-5
Alloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 36 | Get Quote |
![]() ![]() |
10MG | 51 | Get Quote |
![]() ![]() |
25MG | 85 | Get Quote |
![]() ![]() |
50MG | 124 | Get Quote |
![]() ![]() |
100MG | 178 | Get Quote |
![]() ![]() |
200MG | 267 | Get Quote |
![]() ![]() |
500MG | 461 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAlloxazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.
-
DescriptionAlloxazine (Isoalloxazine) is an A2 receptor antagonist, which is approximately 10-fold more selective for the A2B receptor than for the A2A receptor.
-
In VitroAlloxazine (0-30 μM, 20 min) inhibits cyclic AMP production in PGT-β cells. Cell Viability Assay Cell Line:PGT-β cells Concentration:0-30 μM Incubation Time:20 min Result:Inhibited the cyclic AMP generation concentration-dependently with an IC50 of 2.9 μM.
-
In VivoAlloxazine (1 μmol/L; cortical surface suffusion for 0-20 min) suppresses NECA-induced vasodilation. Animal Model:Male Sprague-Dawley rats Dosage:1 μmol/L Administration:Cortical surface suffusion; 1 μmol/L once Result:Significantly suppressed vasodilation with increased EC25 value of 0.60 μmol/L.
-
Synonyms——
-
PathwayApoptosis
-
TargetAdenosine Receptor
-
Recptorglucokinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number490-59-5
-
Formula Weight214.184
-
Molecular FormulaC10H6N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (23.34 mM)
-
SMILESO=c1[nH]c2nc3ccccc3nc2c(=O)[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dzyurkevich MS, et al. Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus. Sci Rep. 2017 Nov 22;7(1):16072.
molnova catalog



related products
-
Methyl protocatechua...
Thermographic recording material with improved image tone
-
Salmeterol
Salmeterol is a long-acting agonist of beta2-adrenergic receptor (beta 2AR) used for treatment ofasthma.
-
A2A receptor antagon...
A2A receptor antagonist 1 is an antagonist of both adenosine A2A receptor and A1 receptor with Kis of 4 and 264 nM, respectively.